|
cardiotrophin-1 |
|---|---|
| Trade Name | |
| Orphan Indication | To protect the liver from ischemia-reperfusion injury inherent to the procedure of transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2008-06-24 00:00:00 |
| Sponsor | Digna Biotech, S.L.;Avenids Carlos III de Noble, Pamplona (Navarra); |
